arrow
S

Shakta Mani Satyam

ras al khaimah medical and health sciences university
H指数:11
被引数:463

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vitamin D–VDR Signaling Across Thyroid Disorders: A Systematic Review of Molecular Mechanisms, Autoimmunity, Genetic Susceptibility, Experimental Evidence and Therapeutic Translation

维生素D–VDR信号通路在甲状腺疾病中的研究:分子机制、自身免疫、遗传易感性、实验证据及治疗转化的系统综述

2026-10-210
OA
Pathological Complete Response to Nab-Paclitaxel–Containing Neoadjuvant Regimens in Early Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

早期三阴性乳腺癌对含Nab-紫杉醇的新辅助方案的病理完全缓解:一项系统评价和Meta分析

2026-09-210
OA
Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes

通过益生元、益生菌、合生元和后生元靶向肠道-骨骼轴:从机制可行性到临床骨骼结局

2026-09-110
OA
Metformin as a Metabolic Reprogramming Interface in Host–Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss

二甲双胍作为宿主-病原体和骨微环境互作中的代谢重编程界面:一种对抗抗菌耐药性和骨质疏松性骨丢失的双靶点策略

2026-06-080
OA
Adenosine Signaling as a Central Integrative Network in Cellular Stress Responses and a Therapeutically Actionable Target in Human Disease

腺苷信号作为细胞应激反应中的中枢整合网络以及在人类疾病中的可治疗作用靶点

2026-05-160
OA
A cost-effective proof-of-concept ex vivo perfusion model for myocardial ischemia–reperfusion injury in wistar rats: enhancing accessibility in resource-constrained settings

一种经济有效的体外灌注模型用于Wistar大鼠心肌缺血-再灌注损伤的可行性研究:提升资源受限环境下的可及性

2026-04-290
OAAI
COVID-19 vaccination remains essential for healthcare professionals: clinical evidence from a Polish cross-sectional study

COVID-19疫苗接种对医疗专业人员仍至关重要:来自波兰横断面研究的临床证据

2026-04-160
OAAI
Correction: Redefining pancreatogenic diabetes mellitus through molecular; imaging; and AI-driven evidence

更正:通过分子、影像学和人工智能驱动的证据重新定义胰腺源性糖尿病 mellitus

2026-04-080
OAAI
Vitamin D supplementation and selected metabolic parameters in patients with type 2 diabetes and obesity: a prospective observational study

维生素D补充剂及选定代谢参数在2型糖尿病和肥胖患者中的研究:一项前瞻性观察性研究

2026-01-150
OAAI
Inclisiran SiRNA therapy for durable LDL-C reduction: a systematic review and meta-analysis highlighting a breakthrough in long-term cardiovascular risk management

Satyam, S.M.; El-Tanani, M.; Patni, M.A.; Rehman, A.; Irshad, S.M.; Raheem, R.; Junais, E.; John, A.A.; Rassal, R.Y.; Kumari, R. Inclisiran SiRNA疗法用于持久降低LDL-C:一项突出长期心血管风险管理突破的系统评价和Meta分析。BMC Cardiovasc. Disord. 2026, 26, 94. [Google Scholar] [CrossRef]

2026-01-101
PRE
Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines

甲苯达唑和吉非替尼通过破坏表皮生长因子受体信号传导和细胞骨架动力学,协同性地损害了非小细胞肺癌和三阴性乳腺癌细胞系中的旁分泌细胞因子信号传导

2025-12-161
PRE